title: The comparison of the effects of ellagic acid and diclofenac sodium on intra-abdominal adhesion: an in vivo study in the rat model.
abstract: Peritoneal adhesions are seen frequently after abdominal surgery and can cause serious complications. We aimed to evaluate the effects of the oral use of diclofenac sodium and ellagic acid on formation of postoperative adhesions in rats Studies have shown that agents with anti-inflammatory properties and antioxidant substances can prevent adhesion by decreasing oxidative stress. We compared and evaluated the effects of ellagic acid that has strong antioxidant and anti-inflammatory properties and the nonsteroidal anti-inflammatory diclofenac sodium on peritoneal adhesion development in our experimental study. Laparotomy was performed with a midline incision under general anesthesia and an adhesion model was created on the antimesenteric side of the cecum in Groups I, II, and III. Group I received 85 mg/kg ellagic acid and Group II, 50 mg/kg diclofenac sodium through the nasogastric catheter while Group III received no medication. Only laparotomy was performed in Group IV. The rats were sacrificed at the end of the 14th day. Following macroscopic scoring, tissue samples were removed and subjected to biochemical and histopathologic evaluation. The degree of adhesion and the malondialdehyde level were decreased (P < 0.05), and glutathione level increased (P < 0.05) in Group I compared to Group II and Group III. The effects of ellagic acid on the prevention of peritoneal adhesion were found to be stronger than diclofenac sodium. This can be explained by the fact that ellagic acid is a strong antioxidant and decreases oxidative stress with anti-inflammatory and anti-angiogenic effects.
authors.affiliation: 1 Department of General Surgery, Kafkas University, Kars, Turkey.
authors.forename: Tulay Diken
authors.initials: TD
authors.lastname: Allahverdi
authors.forename: Ertuğrul
authors.initials: E
authors.lastname: Allahverdi
authors.forename: Sadık
authors.initials: S
authors.lastname: Yayla
authors.forename: Turgay
authors.initials: T
authors.lastname: Deprem
authors.forename: Oğuz
authors.initials: O
authors.lastname: Merhan
authors.forename: Sevil
authors.initials: S
authors.lastname: Vural
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D004008:Diclofenac / Q000008:administration & dosage / Q000627:therapeutic use*; D004610:Ellagic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D010532:Peritoneal Diseases / Q000473:pathology / Q000517:prevention & control*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D004008:Diclofenac; D004610:Ellagic Acid
keywords: Diclofenac sodium; Ellagic acid; Intraabdominal adhesion; Rat